The article reviews the main molecular pathology alterations of endometrial and ovarian carcinomas and melanoma. Several promising drugs targeting the genes most frequently altered in these tumors are under consideration. The most promising signaling pathways to be targeted for therapies in these tumors are the tyrosine kinase receptor (EGFR, HER2, c-KIT), the RAS/B-RAF/MAPK, the PI3K-mTOR, and apoptosis signaling pathways.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.semdp.2008.07.008 | DOI Listing |
Publication Analysis
Top Keywords
targeted therapies
8
signaling pathways
8
therapies gynecologic
4
gynecologic cancers
4
cancers melanoma
4
melanoma article
4
article reviews
4
reviews main
4
main molecular
4
molecular pathology
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!